Hanley, Colleen M <br/><br/>
Status of Antiarrhythmic Drug Development for Atrial Fibrillation: New Drugs and New Molecular Mechanisms.  [electronic resource] 

 -  Circulation. Arrhythmia and electrophysiology  Mar 2016 
 - e002479 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1941-3084 
<br/><br/><label>Standard No.: </label>10.1161/CIRCEP.115.002479  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Action Potentials<br/>Animals<br/>Anti-Arrhythmia Agents--adverse effects<br/>Atrial Fibrillation--diagnosis<br/>Drugs, Investigational--adverse effects<br/>Heart Conduction System--drug effects<br/>Heart Rate--drug effects<br/>Humans<br/>Molecular Targeted Therapy<br/>Treatment Outcome